Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
JPM 2022
Biotech
Sage wants to 'raise the bar' on depression meds
Existing meds haven't delivered on treating the depression that impacts millions of Americans, and Sage wants to fix that with quick start zuranolone.
Kyle LaHucik
Jan 19, 2022 4:30pm
Johnson & Johnson's JLABS: Taming the beast
Jan 19, 2022 3:30pm
Bayer's new R&D chief wants to push past Aspirin legacy
Jan 18, 2022 12:10pm
Pharma reflects on the 'aha! moments' of the pandemic
Jan 18, 2022 11:30am
Bausch + Lomb files IPO for its eye care spinout
Jan 14, 2022 10:45am
JPM 2022: Licensing and research tie-ups trump M&A
Jan 14, 2022 9:30am
